A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
Open Access
- 28 March 2014
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 4509
Abstract
HsTX1 toxin, from the scorpion Heterometrus spinnifer, is a 34-residue, C-terminally amidated peptide cross-linked by four disulfide bridges. Here we describe new HsTX1 analogues with an Ala, Phe, Val or Abu substitution at position 14. Complexes of HsTX1 with the voltage-gated potassium channels Kv1.3 and Kv1.1 were created using docking and molecular dynamics simulations, then umbrella sampling simulations were performed to construct the potential of mean force (PMF) of the ligand and calculate the corresponding binding free energy for the most stable configuration. The PMF method predicted that the R14A mutation in HsTX1 would yield a > 2[emsp14]kcal/mol gain for the Kv1.3/Kv1.1 selectivity free energy relative to the wild-type peptide. Functional assays confirmed the predicted selectivity gain for HsTX1[lsqb]R14A[rsqb] and HsTX1[lsqb]R14Abu[rsqb], with an affinity for Kv1.3 in the low picomolar range and a selectivity of more than 2,000-fold for Kv1.3 over Kv1.1. This remarkable potency and selectivity for Kv1.3, which is significantly up-regulated in activated effector memory cells in humans, suggest that these analogues represent valuable leads in the development of therapeutics for autoimmune diseases.Keywords
This publication has 30 references indexed in Scilit:
- A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental ConfirmationPLOS ONE, 2013
- Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer LymphocytesPLOS ONE, 2013
- Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesToxicon, 2012
- Accurate Determination of the Binding Free Energy for KcsA-Charybdotoxin Complex from the Potential of Mean Force Calculations with RestraintsBiophysical Journal, 2011
- Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid TypesThe Journal of Physical Chemistry B, 2010
- Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T LymphocytesMolecular Pharmacology, 2009
- Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel BlockImmunity, 2008
- Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesProceedings of the National Academy of Sciences, 2006
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996